Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.925 | 0.160 | 17 | 16945825 | intron variant | A/G | snv | 0.13 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases | 0.810 | 1.000 | 2 | 2013 | 2014 | |||||||
|
17 | 16946499 | intron variant | G/C | snv | 0.22 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
0.925 | 0.040 | 17 | 16940375 | stop gained | GG/CC;TT | mnv |
|
Immune System Diseases | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||||||
|
17 | 16931972 | intron variant | C/A;T | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||||
|
17 | 16948520 | intron variant | C/T | snv | 0.35 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
0.925 | 0.160 | 17 | 16945825 | intron variant | A/G | snv | 0.13 |
|
Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.925 | 0.160 | 17 | 16945825 | intron variant | A/G | snv | 0.13 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
0.925 | 0.160 | 17 | 16945825 | intron variant | A/G | snv | 0.13 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
17 | 16945436 | intron variant | C/T | snv | 0.12 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
17 | 16945436 | intron variant | C/T | snv | 0.12 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
17 | 16945436 | intron variant | C/T | snv | 0.12 |
|
0.700 | 1.000 | 1 | 2013 | 2013 | ||||||||||
|
17 | 16941853 | intron variant | A/G | snv | 0.12 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
17 | 16962761 | intron variant | C/A | snv | 0.66 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
0.925 | 0.120 | 17 | 16960324 | intron variant | C/G | snv | 0.11 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.925 | 0.120 | 17 | 16960324 | intron variant | C/G | snv | 0.11 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.925 | 0.120 | 17 | 16960324 | intron variant | C/G | snv | 0.11 |
|
0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.925 | 0.120 | 17 | 16960324 | intron variant | C/G | snv | 0.11 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.925 | 0.120 | 17 | 16960324 | intron variant | C/G | snv | 0.11 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
17 | 16965247 | intron variant | C/G;T | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||||
|
0.925 | 0.080 | 17 | 16936468 | intron variant | A/T | snv | 0.16 |
|
Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.925 | 0.080 | 17 | 16936468 | intron variant | A/T | snv | 0.16 |
|
Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.925 | 0.040 | 17 | 16940375 | stop gained | GG/CC;TT | mnv |
|
0.700 | 0 | ||||||||||||
|
1.000 | 17 | 16972027 | frameshift variant | G/- | delins |
|
0.700 | 0 | |||||||||||||
|
1.000 | 17 | 16948978 | frameshift variant | -/T | delins | 4.0E-06; 4.1E-04 | 3.0E-04 |
|
0.700 | 1.000 | 7 | 2005 | 2016 | ||||||||
|
17 | 16940378 | stop gained | G/A;C;T | snv | 1.2E-05; 4.0E-06; 5.6E-05 |
|
Female Urogenital Diseases and Pregnancy Complications; Infections | 0.010 | 1.000 | 1 | 2019 | 2019 |